A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
NCT06662643 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2024-10-29
Summary
This study targets patients undergoing ultra-low rectal cancer surgery, which requires internal sphincter resection for sphincter-saving procedures. The study compares the staged Turnbull-Cutait Pull-through anastomosis (a delayed transanal pull-through anastomosis without a protective stoma) as the experimental group with traditional anastomosis (hand-sewn/stapled) plus protective ileostomy as the control group. The aim is to assess whether the Turnbull-Cutait Pull-through colon-anal anastomosis is non-inferior to traditional ISR surgery in terms of complications (short-term such as anastomotic leakage/dehiscence, pelvic infection, anastomotic bleeding, ischemic bowel necrosis, bowel obstruction, and long-term complications such as anastomotic stricture, perianastomotic fistula, bowel obstruction, stoma-related complications, and others), postoperative anal function, quality of life, long-term oncologic outcomes, hospital stay duration, and total hospitalization costs.
Conditions
- Rectal Cancer
- Rectal Carcinoma
Interventions
- PROCEDURE
-
Delayed transanal pull-through anastomosis
Laparoscopic surgery is recommended. A standard 5-port method is used to create pneumoperitoneum after placing the trocar. The sigmoid colon and upper rectal mesentery are dissected along Toldt's fascia. Autonomic nerves should be preserved, and high ligation of the inferior mesenteric vessels with lymph node dissection is recommended. TME: Using a posterior-to-anterior approach, the mesorectal plane is dissected down to the pelvic floor, cutting the Waldeyer's fascia to enter the intersphincteric space, where sharp dissection is carried out toward the levator ani muscle hiatus. The dissection endpoint is the dentate line, where the proximal colon is exteriorized by at least 2 cm and sutured to the anal canal with 6-8 stitches, without a protective ileostomy.Two to four weeks after the first surgery, after the colon has adhered well to the surrounding tissue, the exteriorized colon is excised (under epidural or spinal anesthesia, trimming the exteriorized colon to form the anus).
- PROCEDURE
-
Direct Anastomosis Plus Prophylactic Ileostomy
ISR is categorized into partial ISR (PISR), subtotal ISR, and total ISR (TISR). Correspondingly, the anastomosis site after coloanal anastomosis is located below the levator ani hiatus (PISR, near the dentate line; subtotal-ISR and TISR, below the dentate line).The dissection steps are the same as in the first stage of the Staged Turnbull-Cutait Pull-through Anastomosis group (TME and intersphincteric space dissection).The bowel is transected at least 1 cm below the tumor, leaving a larger segment of healthy tissue on the non-tumor side while ensuring that no more than 1/3 of the dentate line is resected to avoid impairing fecal control.Anastomosis is performed using absorbable sutures under direct visualization. A protective ileostomy is created 25-30 cm from the ileocecal valve.3 to 6 months after surgery, the ileostomy is reversed. Prior to closure, digital rectal examination, defecography, MRI, colonoscopy, and other evaluation must perform.
Sponsors & Collaborators
-
Ezhou Central Hospital
collaborator UNKNOWN -
Jingzhou Central Hospital
collaborator OTHER -
Taihe Hospital
collaborator OTHER -
Hubei University of Medicine
collaborator OTHER -
Qilu Hospital of Shandong University
collaborator OTHER -
Beijing Chao Yang Hospital
collaborator OTHER -
Tianmen First People's Hospital
collaborator UNKNOWN -
Xiangyang Central Hospital
collaborator OTHER -
First People's Hospital of Xianyang
collaborator OTHER -
Central Hospital of Xiaogan
collaborator OTHER -
Yichang Central People's Hospital
collaborator OTHER -
Yichang Second People's Hospital
collaborator OTHER -
Rocket Force Special Medical Center of the People's Liberation Army
collaborator UNKNOWN -
Huashan Hospital
collaborator OTHER -
Zhongnan Hospital
lead OTHER
Principal Investigators
-
Congqing Jiang, MD, PhD · Department of colorectal and anal surgery, Zhongnan Hospital of Wuhan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-08
- Primary Completion
- 2026-05-30
- Completion
- 2029-12-30
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer
NCT00949273 ·Status: UNKNOWN
-
Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy
NCT03548844 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site
NCT03253302 ·Status: UNKNOWN
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2
-
Single-port Robotic Transanal Total Mesorectal Excision
NCT06591572 ·Status: COMPLETED ·Phase: NA
-
Stoma Discharge Reinfusion After Sphincter Preservation for Middle and Low Rectal Cancer
NCT05461248 ·Status: COMPLETED ·Phase: NA
-
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
NCT01437514 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT03042000 ·Status: UNKNOWN ·Phase: NA
-
Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.
NCT06613399 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cross-sectional Study of Anorectal Function and Quality of Life in Patients With Middle and Low Rectal Cancer
NCT04697303 ·Status: COMPLETED
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
NCT02860234 ·Status: COMPLETED
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer
NCT06454201 ·Status: COMPLETED ·Phase: NA
-
Extended Resection for Rectal Cancer With Neoadjuvant Radiotherapy
NCT05267275 ·Status: RECRUITING ·Phase: NA
-
Transanal Total Mesorectal Excision Versus Robotic Total Mesorectal Excision
NCT04091620 ·Status: UNKNOWN ·Phase: NA
-
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer
NCT03209336 ·Status: UNKNOWN ·Phase: NA
-
Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer
NCT06405308 ·Status: COMPLETED
-
Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer
NCT03597126 ·Status: UNKNOWN ·Phase: NA
-
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer
NCT02817126 ·Status: UNKNOWN ·Phase: NA
-
Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR
NCT04012645 ·Status: RECRUITING ·Phase: NA
-
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
NCT06824688 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING